BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 3970930)

  • 1. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G; Abraham AK; Vedeler A
    FEBS Lett; 1986 Nov; 208(2):217-20. PubMed ID: 3780964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of elongation factor 2 (EF-2) with guanine nucleotides and ribosomes. Binding of periodate-oxidized guanine nucleotides to EF-2.
    Nurten R; Bermek E
    Eur J Biochem; 1980 Feb; 103(3):551-5. PubMed ID: 6244163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic determination of the effects of ADP-ribosylation on the interaction of eukaryotic elongation factor 2 with ribosomes.
    Nygård O; Nilsson L
    J Biol Chem; 1990 Apr; 265(11):6030-4. PubMed ID: 2318846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of the reactivity of three amino-acid residues in elongation factor 2 during its binding to ribosomes and translocation.
    Lavergne JP; Marzouki A; Reboud AM; Reboud JP
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):231-7. PubMed ID: 2322578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 on translocation.
    Montanaro L; Sperti S; Testoni G; Mattioli A
    Biochem J; 1976 Apr; 156(1):15-23. PubMed ID: 182140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A; Sontag B; Lavergne JP; Vidonne C; Reboud JP; Reboud AM
    Biochimie; 1991; 73(7-8):1151-6. PubMed ID: 1742357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced turnover of the elongation factor EF-1 X ribosome complex after treatment with the protein synthesis inhibitor II from barley seeds.
    Nilsson L; Asano K; Svensson B; Poulsen FM; Nygård O
    Biochim Biophys Acta; 1986 Oct; 868(1):62-70. PubMed ID: 3756169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK; Ovchinnikov LP
    FEBS Lett; 1990 Feb; 261(2):350-2. PubMed ID: 2311763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS; Davydova EK; Bezlepkina TA; Ovchinnikov LP; Spirin AS
    FEBS Lett; 1984 Oct; 176(2):406-10. PubMed ID: 6208057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A; Balestrieri C; Quagliuolo L; Servillo L
    FEBS Lett; 1985 Oct; 191(2):191-4. PubMed ID: 2996930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide-mediated interactions of eukaryotic elongation factor EF-2 with ribosomes.
    Nygård O; Nilsson L
    Eur J Biochem; 1984 Apr; 140(1):93-6. PubMed ID: 6705799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the ribosomal properties required for formation of a GTPase active complex with the eukaryotic elongation factor 2.
    Nygård O; Nilsson L
    Eur J Biochem; 1989 Feb; 179(3):603-8. PubMed ID: 2537725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of adenosine diphosphate-ribosylated elongation factor 2 with ribosomes.
    Bermek E
    J Biol Chem; 1976 Nov; 251(21):6544-9. PubMed ID: 789367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of the protein-synthesis elongation cycle in eukaryotes. Effect of ricin on the ribosomal interaction with elongation factors.
    Nilsson L; Nygård O
    Eur J Biochem; 1986 Nov; 161(1):111-7. PubMed ID: 3780730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional groups of elongation factor 2 involved in interactions with guanosine nucleotides and ribosomes.
    Nurten R; Aktar NB; Bermek E
    FEBS Lett; 1983 Apr; 154(2):391-4. PubMed ID: 6832378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribosomes terminated in vitro are in a tight association with non-phosphorylated elongation factor 2 (eEF-2) and GDP.
    Davydova EK; Malinin NL; Ovchinnikov LP
    Eur J Biochem; 1993 Jul; 215(2):291-6. PubMed ID: 8344297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the sites of ADP-ribosylation and GTP binding in the eukaryotic elongation factor EF-2.
    Nilsson L; Nygård O
    Eur J Biochem; 1985 Apr; 148(2):299-304. PubMed ID: 3987690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ribosomal binding site for eukaryotic elongation factor EF-2 contains 5 S ribosomal RNA.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1987 Jan; 908(1):46-53. PubMed ID: 3801485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the accessibility of ribosomal proteins after elongation factor 2 binding to rat liver ribosomes and during translocation.
    Marzouki A; Lavergne JP; Reboud JP; Reboud AM
    Biochim Biophys Acta; 1990 Apr; 1048(2-3):238-44. PubMed ID: 2322579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.